Supplementary Table from AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts

Kate F. Byth,Andrew Thomas,Gareth Hughes, Cheryl Forder,Alexandra McGregor,Catherine Geh, Sandra Oakes,Clive Green,Mike Walker, Nicholas Newcombe,Stephen Green,Jim Growcott, Andy Barker,Robert W. Wilkinson

crossref（2023）

引用 0|浏览2

暂无评分

摘要

Supplementary Table from AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要